Skip to content
‹ Back to IndustriesSciences

Can Intermittent Fasting Help You Lose Weight And Provide Other Health Benefits?

While it has been widely promoted as a weight loss strategy, research suggests that intermittent fasting may have broader benefits for overall health and well-being. A study published in the New England Journal of Medicine found that Intermittent Fasting can help lower blood pressure, improve insulin sensitivity, and reduce the risk of chronic diseases such…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Healthcare · · DietFastingHealthHealth Benefits
Share

Key takeaways

01

While it has been widely promoted as a weight loss strategy, research suggests that intermittent fasting may have broader benefits for overall health and well-being.

02

A study published in the New England Journal of Medicine found that Intermittent Fasting can help lower blood pressure, improve insulin sensitivity, and reduce the risk of chronic diseases such…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

While it has been widely promoted as a weight loss strategy, research suggests that intermittent fasting may have broader benefits for overall health and well-being. A study published in the New England Journal of Medicine found that Intermittent Fasting can help lower blood pressure, improve insulin sensitivity, and reduce the risk of chronic diseases such as diabetes and heart disease.

Another study in the journal Cell Metabolism found that Intermittent Fasting can increase the production of a protein called brain-derived neurotrophic factor (BDNF), which is essential for the growth and maintenance of neurons in the brain.

Despite these promising findings, new research found that intermittent fasting may not be as beneficial for weight loss as previously thought while another study found that that it does not bring the same health benefits as other weight loss programs.

These new findings leave lots of questions unanswered. Does intermittent fasting help with weight loss and provide other health benefits or is it just another fad diet targeted to those who are looking to lose weight? Kimberly Gomer, director of nutrition at Body Beautiful Miami, is a leading nutritional expert in weight loss and medical nutrition for over 2 decades. She brings her years of experience to the discussion and offers her in-depth analysis of this dietary strategy.

Kim’s Thoughts:

I love this article on intermittent fasting because it brings to light an unknown idea for a lot of people. I do believe from the science, looking at the science, that there is benefit to time-restricted eating. So, you’re fasting for a certain amount of time and then you’re eating. The idea that immune autophagy maintaining muscle mass is a possibility with fasting.

But the exciting part for me as a nutritionist is the stability of blood sugar. Because high insulin levels, high blood sugars are a huge problem in the United States—we are looking at one in three people with prediabetes. We are looking at one in 10 people with diabetes, and we are looking at one in five people who don’t even know they have it.

So, this idea that we can lower insulin levels and we can stabilize blood sugar and do it through an intermittent fasting lifestyle, is amazing. And part of the science behind it is that when you are not eating, be it sleeping or just not eating, your insulin is very low. It’s the lowest when you’re not eating so allowing for a time that you are not eating in your day to be extended and eating only in a certain window, there are a lot of health benefits.

The problem that I see with some of these articles and understanding how they would apply to you as an individual is the fasting times are all over the place. Are you fasting for 18 hours a day? Are you fasting for 16 hours a day? Are you fasting for 12 hours a day?

Is your eating window very short? One to three hours or long eight hours. So, this idea of what is the best fasting and eating window is still not clear in some of the research, and more important in my mind, yes, intermittent fasting is a great tool. I use it in my private practice as a dietician with a lot of success.

But one thing that has to come with it is what are you eating? We live in a world of obesogenic food, highly processed, unhealthy food. So, some of my clients actually think, some people think well I can fast for 20 hours and for four hours I can go and eat fast food and eat junk, and I’m going to be healthy and thin. Not true.

So, I love intermittent fasting, I think we need more and more research about it. I think people need to be clear about what will work for them, how the tool can work for them as an individual, and more importantly, be clear about what they’re actually eating during their window. Again, I’m going to say I think that intermittent fasting is an awesome tool.

I’m so happy to see research being published. More research needs to be done and I think it can be very useful for a lot of people. Thank you.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

H
Healthcare
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

  • 01Orthotopic brain tumor implantation using tagged models lets researchers track tumor growth in the original organ, aligning the model and delivery route with how therapies are intended to be tested.
  • 02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
  • 03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

H
Healthcare

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512